Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma

Abhinav Kaushik1, Yashuma Bhatia1, Shakir Ali2

  • 1Bioinformatics Laboratory, Structural and Computational Biology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.

Plos One
|November 13, 2015
PubMed

Insights

Metastatic melanoma progression involves complex gene rewiring, not just differential expression. This study reveals conserved network alterations and identifies key disease genes, aiding in understanding melanoma heterogeneity and potential drug targets.

Area of Science:

  • Genomics
  • Systems Biology
  • Bioinformatics

Background:

  • Metastatic melanoma presents a poor prognosis due to genetic heterogeneity and altered gene expression.
  • Developing targeted therapies for metastatic melanoma is challenging.
  • Systems biology can identify dysregulated genes not detected by differential expression analysis.

Purpose of the Study:

  • To explore conserved properties of disease genes and gene sets across melanoma progression using systems biology.
  • To identify genes with altered molecular circuitry in melanoma compared to normal states.
  • To enhance understanding of metastatic melanoma pathogenesis.

Main Methods:

  • Meta-analysis of 642 microarray samples to generate melanoma progression networks.
  • Identification of genes with altered network wiring using systems biology approaches.
  • Analysis of network connectivity and properties of disease gene sets.

Main Results:

  • A majority of melanoma-rewired genes are not differentially expressed.
  • Disease genes modulate melanoma progression through network rewiring, with enhanced connectivity during progression.
  • Distinct network hubs emerge in different metastatic stages for conserved pathways.
  • A freely available database (http://bioinfo.icgeb.res.in/m3db/) of results was created.

Conclusions:

  • Conserved network rewiring, rather than just differential gene expression, is crucial in metastatic melanoma.
  • Network properties of disease genes offer insights into melanoma progression and potential therapeutic strategies.
  • The developed database provides a valuable resource for further melanoma research and drug target identification.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K